Filing metadata

Accession number
0001127602-25-021056
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Sep 02, 2025
Reporting period
Aug 26, 2025
Description
Insider transaction

Explore SEC Filings Hub